Myelin-induced experimental allergic encephalomyelitis in Lewis rats: tumor necrosis factor α levels in serum and cerebrospinal fluid Immunohistochemical expression in glial cells and macrophages of optic nerve and spinal cord

Aderka, 1991, Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients, Cancer Res., 51, 5602 Aderka, 1992, Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors, J. Exp. Med., 175, 323, 10.1084/jem.175.2.323 Baker, 1994, Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins, Eur.J. Immunol., 24, 2040, 10.1002/eji.1830240916 Beutler, 1986, Cachectin and tumor necrosis factor as two sides of the same biological coin, Nature, 320, 584, 10.1038/320584a0 Beutler, 1986, Control of cachectin (tumor necrosis factor) synthesis: mechanism of endotoxin resistance, Science, 232, 977, 10.1126/science.3754653 Beyaert, 1989, Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo, 86, 9494 Brosnan, 1988, Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis, J. Neuroimmunol., 18, 87, 10.1016/0165-5728(88)90137-3 Brosnan, 1989, Preliminary studies of cytokine-induced functional effects on the visual pathways in the rabbit, J. Neuroimmunol., 25, 227, 10.1016/0165-5728(89)90141-0 Butter, 1991, Mononuclear cells trafficking and plasma protein extravasation into the CNS during chronic relapsing EAE in Biozzi AB/mice, J. Neurol. Sci., 104, 9, 10.1016/0022-510X(91)90209-P Chung, 1991, Differential TNFa expression by astrocytes from EAE-susceptible and resistant rat strains, J. Exp. Med., 173, 801, 10.1084/jem.173.4.801 Fontana, 1982, Production of prostaglandin E and an IL-1-like factor by cultured astrocytes and glioma cells, J. Immunol., 129, 2413, 10.4049/jimmunol.129.6.2413 Franciotta, 1989, Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis, Ann. Neurol., 26, 787, 10.1002/ana.410260618 Kuroda, 1991, Human tumor necrosis factor a augments experimental allergic encephalomyelitis in rats, J. Neuroimmunol., 34, 159, 10.1016/0165-5728(91)90125-Q Maimone, 1991, Cytokine levels in the cerebrospinal fluid and serum of patients with MS, J. Neuroimmunol., 32, 67, 10.1016/0165-5728(91)90073-G Martenson, 1984, A useful model for multiple sclerosis, Vol. 146, 511 Meager, 1989, Assays for rumor necrosis factor and related cytokines, J. Immunol. Methods, 116, 1, 10.1016/0022-1759(89)90306-2 Namer, 1993, Blood-brain barrier breakdown in MBP-specific T cell induced EAE, Brain, 116, 147, 10.1093/brain/116.1.147 Olsson, 1994, Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis, Eur.J. Neurol., 1, 7, 10.1111/j.1468-1331.1994.tb00045.x Ortiz-Ortiz, 1976, Cellular events in the induction of experimental allergic encephalomyelitis in rats, J. Exp. Med., 144, 604, 10.1084/jem.144.3.604 Owens, 1987, Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens, J. Immunol., 138, 2402, 10.4049/jimmunol.138.8.2402 Pelletier, 1988, Effect of HgCl2 on experimental allergic encephalomyelitis in Lewis rats. HgCl2-induced downmodulation of the disease, Eur.J. Immunol., 18, 243, 10.1002/eji.1830180210 Petinelli, 1981, Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement of Lytl+ 2−-T lymphocytes, J. Immunol., 127, 1420, 10.4049/jimmunol.127.4.1420 Powell, 1992, The role of Iymphotoxin and TNF in demyelinating diseases of CNS, 355 Raine, 1984, Immunopathology of the lesion in multiple sclerosis and chronic relapsing EAE, 151 Remick, 1989, Cyclosporin A inhibits TNF production without decreasing TNF mRNA levels, Biochem. Biophys. Res. Commun., 161, 551, 10.1016/0006-291X(89)92634-X Renno, 1994, Cytokine production by cells in CSF during EAE in SJL/J mice, J. Neuroimmunol., 49, 1, 10.1016/0165-5728(94)90174-0 Ruddle, 1990, An antibody to lymphotoxin and TNF prevents transfer of experimental allergic encephalomyelitis, J. Exp. Med., 172, 1193, 10.1084/jem.172.4.1193 Selmaj, 1988, Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro, Ann. Neurol., 23, 339, 10.1002/ana.410230405 Selmaj, 1991, Anti-TNF therapy abrogates autoimmune demyelination, Ann. Neurol., 30, 694, 10.1002/ana.410300510 Selmaj, 1991, Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions, J. Clin. Invest., 87, 949, 10.1172/JCI115102 Sharief, 1992, In vivo relationship of tumor necrosis factor a to blood-brain barrier damage in patients with active multiple sclerosis, J. Neuroimmunol., 38, 27, 10.1016/0165-5728(92)90087-2 Tibbling, 1977, Principles of albumin and IgG analyses in neurological disorders.I. Establishment of reference values, Scand.J. Clin. Lab. Invest., 37, 385, 10.3109/00365517709091496 Trotter, 1991, Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor a levels, J. Neuroimmunol., 33, 29, 10.1016/0165-5728(91)90031-2 Zeine, 1992, Direct demonstration of the infiltration of murine CNS by Pgp-l/CD44 high CD45RB low CD4+ T cells that induce EAE, J. Neuroimmunol., 40, 57, 10.1016/0165-5728(92)90213-5